Laboratorios Ojer Pharma (@ojerpharma) 's Twitter Profile
Laboratorios Ojer Pharma

@ojerpharma

Laboratorios Ojer Pharma is a New Technology-Based Company (NEBTs) that focuses all its efforts on the development of innovative pharmaceutical products .

ID: 1196389625172025346

linkhttp://www.ojerpharma.com calendar_today18-11-2019 11:29:08

9 Tweet

33 Followers

20 Following

Inveready (@inveready) 's Twitter Profile Photo

#OjerPharma y #ReigJofre obtienen la primera autorización europea para la comercialización de su innovador antibiótico Impetine Gel. bit.ly/2pWVQAb ¡Enhorabuena! 👏

#OjerPharma y #ReigJofre obtienen la primera autorización europea para la comercialización de su innovador antibiótico Impetine Gel.  bit.ly/2pWVQAb 
¡Enhorabuena! 👏
Quim L Caussa (@jlcaussa) 's Twitter Profile Photo

Sala llena en la presentación de Laboratorios Ojer Pharma en exclusiva para los inversores de @TheCrowdAngel en colaboración con Inveready ¡Estate atento que la semana que viene va a estar disponible en la plataforma!

Sala llena en la presentación de <a href="/OjerPharma/">Laboratorios Ojer Pharma</a> en exclusiva para los inversores de @TheCrowdAngel  en colaboración con <a href="/inveready/">Inveready</a>

¡Estate atento que la semana que viene va a estar disponible en la plataforma!
Laboratorios Ojer Pharma (@ojerpharma) 's Twitter Profile Photo

3rd VALUE ADDED MEDICINES CONFERENCE, BRUSSELS 21 NOVEMBER 2019. Panellist: Maria Rúbies Royo,BD & RA Manager, Ojer Pharma # VAM19

3rd VALUE ADDED MEDICINES CONFERENCE, BRUSSELS 21 NOVEMBER 2019.
Panellist: Maria Rúbies Royo,BD &amp; RA Manager, Ojer Pharma
# VAM19
Laboratorios Ojer Pharma (@ojerpharma) 's Twitter Profile Photo

Ojer pharma was pleased to participate in L'Oréal Paris`s corporate accelerator program 2019. #Openinnovationprogram #noveltopicalplatform

Ojer pharma was  pleased to participate in L'Oréal Paris`s corporate accelerator program 2019.
#Openinnovationprogram #noveltopicalplatform
Laboratorios Ojer Pharma (@ojerpharma) 's Twitter Profile Photo

Authorization for phase IIa clinical trial has been granted for Keramod Gel, an innovative bioadhesive product which has been designed and developed as a semisolid filmforming formulation for the treatment of Actinic Keratosis. #KeramodGel #clinicaltrial #Actinickeratosis

Authorization for phase IIa clinical trial has been granted for Keramod Gel, an innovative bioadhesive product which has been designed and developed as a semisolid filmforming formulation for the treatment of Actinic Keratosis. #KeramodGel #clinicaltrial #Actinickeratosis